Publication

Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors

Related publications (35)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors

Graph Chatbot

Chat with Graph Search

Artificial intelligence for natural product drug discovery

A multi-reservoir extruder for time-resolved serial protein crystallography and compound screening at X-ray free-electron lasers

Optimised three-dimensional in vitro retinoblastoma models tailored for drug discovery and clinical translatability

Repurposed drug combination via high-throughput screening and dual drug delivery system development for the treatment of retinoblastoma

NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism

High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer

Miniaturized technologies for high-throughput drug screening enzymatic assays and diagnostics - A review

Macrocycle synthesis strategy based on step-wise “adding and reacting” three components enables screening of large combinatorial libraries

Extrapolating the Fragment-Based Approach to Inorganic Drug Discovery

Design and validation of bioorthogonal probes for cellular disease models